InPsytech Announces Finalization of UCIe IP Design, Driving Breakthroughs in High-Speed Transmission Technology
January 15, 2025, Hsinchu, Taiwan -- InPsytech, Inc., a global leader in high-speed interface IP, has announced significant advancements in the performance and efficiency of its Universal Chiplet Interconnect Express (UCIe) product line. The next-generation UCIe physical layer IP, based on 4nm process, is expected to finalize its design later this year, supporting data transmission speeds of up to 64 GT/s per channel. This breakthrough highlights the company’s technological prowess in high-bandwidth applications.
With extensive experience in mass production, InPsytech has successfully collaborated with a renowned global AI company to mass-produce high-speed interface IP on 5nm process. The new UCIe IP further pushes the boundaries of transmission speed and achieves exceptional data stability, providing robust support for high-bandwidth applications such as artificial intelligence (AI), high-performance computing (HPC), and networking.
InPsytech also announced the successful acquisition of multiple groundbreaking patents for UCIe technology. These patents focus on innovative connection interfaces and channel linking methods to address the reliability challenges of current substrate channel connections. Traditional technologies often experience signal degradation or transmission interruptions over extended use. The patented solutions offer revolutionary methods to resolve these issues. Another patent enables automatic detection of data output deviations from the safety range, triggering processing circuits immediately to ensure data input accuracy and stability.
Jason Chen, Senior Vice President of R&D at InPsytech, stated: “The successful deployment of these patents not only reflects InPsytech’s exceptional capabilities in technological innovation but also solidifies our leading position in the high-speed interface IP field. The next-generation UCIe IP, launching this year, achieves a groundbreaking transmission speed of 64 GT/s per channel, providing critical support to shorten customers’ design cycles and accelerate time-to-market.”
About InPsytech
InPsytech, a subsidiary of Egis Technology, is a global leader in high-speed interface IP technology. The company specializes in high-performance, low-power silicon IP solutions applied in artificial intelligence (AI), high-performance computing (HPC), automotive electronics, and high-speed communications. With deep technical expertise and a spirit of innovation, InPsytech continues to deliver cutting-edge solutions to clients worldwide, driving the advancement and growth of the semiconductor industry.
|
Egis Technology Inc Hot IP
Related News
- High-Speed Data Transmission Enhanced by 28nm JESD204B Tx PHY & Controller IP Cores Licensed for MCU Applications
- Unveiling Silicon-proven USB 3.0 PHY IP Core in 22nm, Elevating High-Speed Data Transmission with Advanced Transceiver Technology, backward compatible with USB 2.0
- M31 Successfully Validates 12nm USB4 PHY IP Empowering Next-Generation High-Speed Data Transmission
- InPsytech Joins Intel Foundry Accelerator IP Alliance to Boost HPC, AI, And Automotive Applications
- Logic Fruit Technologies Releases High-Speed Interface IPs Stack for Advanced Computing
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |